Straumann Holding AG (OTCMKTS:SAUHY) Sees Significant Decrease in Short Interest

Straumann Holding AG (OTCMKTS:SAUHYGet Free Report) was the target of a significant decline in short interest in May. As of May 29th, there was short interest totaling 30,585 shares, a decline of 85.1% from the May 14th total of 205,953 shares. Currently, 0.0% of the company’s stock are short sold. Based on an average trading volume of 206,959 shares, the short-interest ratio is presently 0.1 days.

Wall Street Analyst Weigh In

Several research firms have commented on SAUHY. Citigroup restated a “sell” rating on shares of Straumann in a research note on Thursday, April 23rd. Morgan Stanley restated an “underweight” rating on shares of Straumann in a research note on Tuesday, April 14th. One analyst has rated the stock with a Buy rating, two have issued a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Reduce”.

Check Out Our Latest Analysis on Straumann

Straumann Stock Performance

OTCMKTS:SAUHY traded down $0.24 during trading hours on Wednesday, hitting $11.72. The company’s stock had a trading volume of 10,118 shares, compared to its average volume of 174,697. The stock has a fifty day moving average of $11.07 and a 200-day moving average of $11.48. Straumann has a 52-week low of $9.44 and a 52-week high of $14.11.

About Straumann

(Get Free Report)

Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.

In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.

Featured Stories

Receive News & Ratings for Straumann Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Straumann and related companies with MarketBeat.com's FREE daily email newsletter.